Thieler Law Corp advises investors with losses exceeding $100,000 of the October 07, 2019 lead plaintiff deadline in a class action lawsuit filed against Abiomed Inc (NASDAQ: ABMD) (“Abiomed” or “the Company”). The suit is pending in the U.S. District Court for the Southern District of New York and investors, who purchased Abiomed Inc securities between January 31, 2019 and July 31, 2019, have until October 07, 2019 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class.

If you purchased Abiomed Inc securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class.

The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that Abiomed’s revenue growth was in decline; the Company did not have a sufficient plan in place to stem its declining revenue growth; the Company was unlikely to restore its revenue growth over the next several fiscal quarters; consequently, Abiomed was reasonably likely to revise its full-year 2020 guidance in a way that would fall short of the Company’s prior projections and market expectations; and as a result, the Company’s public statements were materially false and misleading at all relevant times.

On August 1, 2019, the Company revealed its financial results for the first quarter of 2020, reporting its third consecutive quarter of slowing revenue growth. The Company also lowered its full year 2020 revenue guidance to a range of $885 to $925 million, from a range of $900 to $945 million, despite prior assurances that it could “correct the course.”

Following this news, NASDAQ: ABMD fell $73.69 per share, or over 26%, to close at $204.87 per share on August 1, 2019, thereby injuring investors.

If you were negatively impacted by your investment in Abiomed Inc securities between January 31, 2019 and July 31, 2019 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Materials are provided for informational purposes only and do not constitute legal advice. We are only licensed to practice law in Germany. We are neither licensed nor qualified to render advice on US Federal or State law.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/

or

Facsimile: +1 (619) 785 – 3185